Omnipaque 300 iohexol 6.47g/10mL Injection ampoule Australie - anglais - Department of Health (Therapeutic Goods Administration)

omnipaque 300 iohexol 6.47g/10ml injection ampoule

ge healthcare australia pty ltd - iohexol, quantity: 647 mg/ml (equivalent: iodine, qty 300 mg/ml) - injection, solution - excipient ingredients: trometamol; sodium calcium edetate; hydrochloric acid; water for injections - indications as at 12 november 2003: intravascular: omnipaque is indicated in adults for angiography, excretory urography and contrast enhancement in computerised tomography. in children, omnipaque is indicated for angiography and urography. oral/body cavities: omnipaque is indicated in adults for arthrography, endoscopic retrograde pancreatography (erp), endoscopic retrograde cholangiopancreatography (ercp), herniography, hysterosalpingography and in adults, children and premature babies for studies of the gastrointestinal tract. indications as at 4 february 2000: intrathecal: omnipaque (r) is indicated for lumbar, thoracic, cervical and total columnar myelography and in computerised tomography of the cns in adults and children.

Omnipaque 240 iohexol 5.18g/10mL Injection ampoule Australie - anglais - Department of Health (Therapeutic Goods Administration)

omnipaque 240 iohexol 5.18g/10ml injection ampoule

ge healthcare australia pty ltd - iohexol, quantity: 518 mg/ml (equivalent: iodine, qty 240 mg/ml) - injection, solution - excipient ingredients: trometamol; sodium calcium edetate; hydrochloric acid; water for injections - indications as at 12 november 2003: intravascular: omnipaque is indicated in adults for angiography, excretory urography and contrast enhancement in computerised tomography. in children, omnipaque is indicated for angiography and urography. oral/body cavities: omnipaque is indicated in adults for arthrography, endoscopic retrograde pancreatography (erp), endoscopic retrograde cholangiopancreatography (ercp), herniography, hysterosalpingography and in adults, children and premature babies for studies of the gastrointestinal tract. indications as at 4 february 2000: intrathecal: omnipaque (r) is indicated for lumbar, thoracic, cervical and total columnar myelography and in computerised tomography of the cns in adults and children.

Omnipaque 180 iohexol 3.88g/10mL injection        ampoule Australie - anglais - Department of Health (Therapeutic Goods Administration)

omnipaque 180 iohexol 3.88g/10ml injection ampoule

ge healthcare australia pty ltd - iohexol, quantity: 388 mg/ml (equivalent: iodine, qty 180 mg/ml) - injection, solution - excipient ingredients: trometamol; sodium calcium edetate; hydrochloric acid; water for injections - intrathecal: omnipaque is indicated for lumbar, thoracic, cervical and total columnar myelography and in computerised tomography of the cns in adults and children. indications as at 12 november 2003: intravascular: omnipaque is indicated in adults for angiography, excretory urography and contrast enhancement in computerised tomography. in children, omnipaque is indicated for angiography and urography. oral/body cavities: omnipaque is indicated in adults for arthrography, endoscopic retrograde pancreatography (erp), endoscopic retrograde cholangiopancreatography (ercp), herniography, hysterosalpingography and in adults, children and premature babies for studies of the gastrointestinal tract.

Omnipaque 350 iohexol 30.2g/40mL Injection ampoule Australie - anglais - Department of Health (Therapeutic Goods Administration)

omnipaque 350 iohexol 30.2g/40ml injection ampoule

ge healthcare australia pty ltd - iohexol, quantity: 755 mg/ml - injection, solution - excipient ingredients: trometamol; sodium calcium edetate; hydrochloric acid; water for injections - indications as at 12 november 2003: intravascular: omnipaque is indicated in adults for angiography, excretory urography and contrast enhancement in computerised tomography. in children, omnipaque is indicated for angiography and urography. oral/body cavities: omnipaque is indicated in adults for arthrography, endoscopic retrograde pancreatography (erp), endoscopic retrograde cholangiopancreatography (ercp), herniography, hysterosalpingography and in adults, children and premature babies for studies of the gastrointestinal tract.

Omnipaque 300 iohexol 25.88g/40mL Injection ampoule Australie - anglais - Department of Health (Therapeutic Goods Administration)

omnipaque 300 iohexol 25.88g/40ml injection ampoule

ge healthcare australia pty ltd - iohexol, quantity: 647 mg/ml (equivalent: iodine, qty 300 mg/ml) - injection, solution - excipient ingredients: trometamol; sodium calcium edetate; hydrochloric acid; water for injections - indications as at 12 november 2003: intravascular: omnipaque is indicated in adults for angiography, excretory urography and contrast enhancement in computerised tomography. in children, omnipaque is indicated for angiography and urography. oral/body cavities: omnipaque is indicated in adults for arthrography, endoscopic retrograde pancreatography (erp), endoscopic retrograde cholangiopancreatography (ercp), herniography, hysterosalpingography and in adults, children and premature babies for studies of the gastrointestinal tract.

Omnipaque 240 iohexol 7.77g/15mL Injection ampoule Australie - anglais - Department of Health (Therapeutic Goods Administration)

omnipaque 240 iohexol 7.77g/15ml injection ampoule

ge healthcare australia pty ltd - iohexol, quantity: 518 mg/ml (equivalent: iodine, qty 240 mg/ml) - injection, solution - excipient ingredients: trometamol; sodium calcium edetate; hydrochloric acid; water for injections - indications as at 12 november 2003: intravascular: omnipaque is indicated in adults for angiography, excretory urography and contrast enhancement in computerised tomography. in children, omnipaque is indicated for angiography and urography. oral/body cavities: omnipaque is indicated in adults for arthrography, endoscopic retrograde pancreatography (erp), endoscopic retrograde cholangiopancreatography (ercp), herniography, hysterosalpingography and in adults, children and premature babies for studies of the gastrointestinal tract.

OMNIPAQUE 240 iohexol 25.9g/50mL injection bottle Australie - anglais - Department of Health (Therapeutic Goods Administration)

omnipaque 240 iohexol 25.9g/50ml injection bottle

ge healthcare australia pty ltd - iohexol, quantity: 518 mg/ml (equivalent: iodine, qty 240 mg/ml) - injection, solution - excipient ingredients: trometamol; hydrochloric acid; sodium calcium edetate; sodium hydroxide; water for injections - indications as at 12 november 2003: intravascular: omnipaque is indicated in adults for angiography, excretory urography and contrast enhancement in computerised tomography. in children, omnipaque is indicated for angiography and urography. oral/body cavities: omnipaque is indicated in adults for arthrography, endoscopic retrograde pancreatography (erp), endoscopic retrograde cholangiopancreatography (ercp), herniography, hysterosalpingography and in adults, children and premature babies for studies of the gastrointestinal tract.

Omnipaque injection 300mg I/ml Malte - anglais - Medicines Authority

omnipaque injection 300mg i/ml

ge healthcare as nycoveien 1, no-0485 oslo, norway - iohexol - solution for injection - iohexol 300 mg i/ml - contrast media

Omnipaque injection 350mg I/ml Malte - anglais - Medicines Authority

omnipaque injection 350mg i/ml

ge healthcare as nycoveien 1, no-0485 oslo, norway - iohexol - solution for injection - iohexol 350 mg i/ml - contrast media

Omnipaque Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

omnipaque

ge healthcare limited t/a ge healthcare - medical diagnostics - iohexol 302 mg/ml equivalent to 140 mg i/ml - solution for injection - 140 mg i/ ml - active: iohexol 302 mg/ml equivalent to 140 mg i/ml excipient: sodium calcium edetate trometamol water for injection